Abudoureyimu M - Search Results

1

Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.

Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, Chu X, Chen P, Wang R. Lai Y, et al. Among authors: abudoureyimu m. Front Oncol. 2019 Nov 5;9:1156. doi: 10.3389/fonc.2019.01156. eCollection 2019. Front Oncol. 2019. PMID: 31750247 Free PMC article. Review.

2

Recent progress in the emerging role of exosome in hepatocellular carcinoma.

Abudoureyimu M, Zhou H, Zhi Y, Wang T, Feng B, Wang R, Chu X. Abudoureyimu M, et al. Cell Prolif. 2019 Mar;52(2):e12541. doi: 10.1111/cpr.12541. Epub 2018 Nov 5. Cell Prolif. 2019. PMID: 30397975 Free PMC article. Review.

3

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma.

Zhi Y, Abudoureyimu M, Zhou H, Wang T, Feng B, Wang R, Chu X. Zhi Y, et al. Among authors: abudoureyimu m. Mol Ther Nucleic Acids. 2019 Jun 7;16:576-588. doi: 10.1016/j.omtn.2019.04.008. Epub 2019 Apr 17. Mol Ther Nucleic Acids. 2019. PMID: 31082791 Free PMC article.

4

Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.

Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X. Abudoureyimu M, et al. Front Oncol. 2019 Nov 8;9:1182. doi: 10.3389/fonc.2019.01182. eCollection 2019. Front Oncol. 2019. PMID: 31781493 Free PMC article. Review.

5

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.

Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, Chu X, Chen P, Wang R. Lai Y, et al. Among authors: abudoureyimu m. Front Oncol. 2020 Mar 3;10:277. doi: 10.3389/fonc.2020.00277. eCollection 2020. Front Oncol. 2020. PMID: 32195187 Free PMC article.

6

Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.

Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X. Abudoureyimu M, et al. Front Oncol. 2020 May 5;10:701. doi: 10.3389/fonc.2020.00701. eCollection 2020. Front Oncol. 2020. PMID: 32432043 Free PMC article.

7

The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.

Zhou H, Feng B, Abudoureyimu M, Lai Y, Lin X, Tian C, Huang G, Chu X, Wang R. Zhou H, et al. Among authors: abudoureyimu m. Life Sci. 2020 Nov 15;261:118362. doi: 10.1016/j.lfs.2020.118362. Epub 2020 Aug 29. Life Sci. 2020. PMID: 32871184 Free article. Review.

8

The role of Aurora-A in human cancers and future therapeutics.

Lin X, Xiang X, Hao L, Wang T, Lai Y, Abudoureyimu M, Zhou H, Feng B, Chu X, Wang R. Lin X, et al. Among authors: abudoureyimu m. Am J Cancer Res. 2020 Sep 1;10(9):2705-2729. eCollection 2020. Am J Cancer Res. 2020. PMID: 33042612 Free PMC article. Review.

9

Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.

Lai Y, Huang H, Abudoureyimu M, Lin X, Tian C, Wang T, Chu X, Wang R. Lai Y, et al. Among authors: abudoureyimu m. Am J Cancer Res. 2020 Dec 1;10(12):4066-4084. eCollection 2020. Am J Cancer Res. 2020. PMID: 33414986 Free PMC article. Review.

10

Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression.

Tian C, Abudoureyimu M, Lin X, Chu X, Wang R. Tian C, et al. Among authors: abudoureyimu m. Cell Death Dis. 2021 Nov 5;12(11):1047. doi: 10.1038/s41419-021-04303-5. Cell Death Dis. 2021. PMID: 34741030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters